Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03732352
What this trial is testing

18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma

Who this might be right for
EGFR Gene AmplificationEGFR Gene MutationGlioblastoma+3 more
Jonsson Comprehensive Cancer Center 12
Early research (Phase 1)Study completedNCT01547546
What this trial is testing

GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma

Who this might be right for
Glioblastoma, Glioma
Genentech, Inc. 29
Not applicableEnded earlyNCT01954576
What this trial is testing

NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
GlioblastomaBrain Neoplasms
University of Florida 21
Testing effectiveness (Phase 2)Ended earlyNCT04406272
What this trial is testing

VB-111 in Surgically Accessible Recurrent/Progressive GBM

Who this might be right for
GlioblastomaRecurrent Glioblastoma
Dana-Farber Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT02626364
What this trial is testing

Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification

Who this might be right for
Recurrent/Refractory Glioblastoma
Arog Pharmaceuticals, Inc. 11
Testing effectiveness (Phase 2)Study completedNCT01113398
What this trial is testing

AMG 102 and Avastin for Recurrent Malignant Glioma

Who this might be right for
Glioblastoma MultiformeGliosarcoma
Katy Peters 36
Large-scale testing (Phase 3)Study completedNCT00003293
What this trial is testing

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer
Not applicableWithdrawnNCT02194452
What this trial is testing

Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors

Who this might be right for
Acoustic SchwannomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+92 more
Sue O'Dorisio
Early research (Phase 1)Study completedNCT00612638
What this trial is testing

Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas

Who this might be right for
GlioblastomaGliosarcoma
Duke University 96
Large-scale testing (Phase 3)Ended earlyNCT02414165
What this trial is testing

The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic Astrocytoma
Tocagen Inc. 403
Not applicableStudy completedNCT03557372
What this trial is testing

Mathematical Model-Adapted Radiation In Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Dana-Farber Cancer Institute 14
Early research (Phase 1)Study completedNCT00363272
What this trial is testing

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)WithdrawnNCT00021307
What this trial is testing

Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01026493
What this trial is testing

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 257
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT00003134
What this trial is testing

Irinotecan in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 64
Testing effectiveness (Phase 2)Study completedNCT00392171
What this trial is testing

The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)

Who this might be right for
GliomaAstrocytomaOligodendroglioma+1 more
Merck Sharp & Dohme LLC 120
Testing effectiveness (Phase 2)Study completedNCT00540722
What this trial is testing

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 56
Large-scale testing (Phase 3)UnknownNCT00003788
What this trial is testing

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Colorado Health Foundation 270
Early research (Phase 1)Study completedNCT00006474
What this trial is testing

Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Next Page